The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATING CHANGES: Barclays, Nomura Cut Unilever Price Target

Tue, 01st Oct 2013 09:52

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning and Monday afternoon:
----------
FTSE 100
----------
PANMURE GORDON REPLACES SHIRE WITH HIKMA AS 'TOP PICK'
----------
MORGAN STANLEY RAISES BT GROUP PRICE TARGET TO 350 (310) PENCE - 'EQUAL-WEIGHT'
----------
Jefferies reiterates Buy rating for Kingfisher and increases its target price to 440p, from 400p
----------
HSBC RAISES VODAFONE PRICE TARGET TO 255 (230) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES VODAFONE PRICE TARGET TO 255 (230) PENCE - 'OVERWEIGHT'
----------
NOMURA CUTS UNILEVER NV PRICE TARGET TO 32.25 (34.30) EUR - 'BUY'
----------
BARCLAYS CUTS UNILEVER NV PRICE TARGET TO 35 (36) EUR - 'OVERWEIGHT'
----------
TRADERS: SOCGEN CUTS BRITISH LAND TO 'HOLD' ('BUY')
----------
S&P CAPITAL IQ CUTS RIO TINTO TO 'SELL' ('BUY') - PRICE TARGET 2,700 (3,800) PENCE
----------
FTSE 250
----------
PANMURE CUTS LADBROKES PRICE TARGET TO 171 (188) PENCE - 'HOLD'
----------
PANMURE RAISES AVEVA GROUP PRICE TARGET TO 2374 (2174) PENCE - 'HOLD'
----------
HSBC RAISES STAGECOACH TO 'NEUTRAL' ('UNDERWEIGHT') - TARGET 325 (305) PENCE
----------
HSBC RAISES NATIONAL EXPRESS PRICE TARGET TO 290 (280) PENCE - 'OVERWEIGHT'
----------
Goldman Sachs CUTS HIKMA PHARMACEUTICALS PRICE TARGET TO 1180 (1190) PENCE - 'NEUTRAL'
----------
HSBC RAISES FIRSTGROUP PRICE TARGET TO 115 (110) PENCE - 'NEUTRAL'
----------
HSBC RAISES GO-AHEAD GROUP PRICE TARGET TO 1810 (1635) PENCE - 'OVERWEIGHT'
----------
DEUTSCHE BANK RAISES HAYS PRICE TARGET TO 105 (90) PENCE - 'HOLD'
----------
TRADERS: SOCGEN CUTS SEGRO TO 'HOLD' ('BUY')
----------
TRADERS: SOCGEN CUTS DERWENT TO 'HOLD' ('BUY')
----------
NOMURA CUTS LADBROKES PRICE TARGET TO 145 (165) PENCE - 'REDUCE'
----------
ALL-SHARE AND AIM
----------
WH Ireland raises Findel target price to 310p from 250p, reiterating a Buy rating
----------
CS CUTS AFRICAN MINERALS TO 'NEUTRAL' ('OUTPERFORM') - TARGET 280 (350) PENCE
----------
PANMURE RAISES INNOVATION GROUP PRICE TARGET TO 41 (38) PENCE - 'BUY'
----------
CANACCORD RAISES HELLERMANNTYTON PRICE TARGET TO 295 (280) PENCE - 'BUY'
----------
CANACCORD CUTS IOMART GROUP TO 'HOLD' ('BUY') - TARGET 300 PENCE
----------
NUMIS RAISES RENEW HOLDINGS PRICE TARGET TO 185 (148) PENCE - 'BUY'
----------
JPM RAISES NEW WORLD RESOURCES PRICE TARGET TO 59 (50) PENCE - 'UNDERWEIGHT'
----------
Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.